Clinical Trial Update: A Clinical Trial to Assess the Safety and PK of OMN6 in HABP or VABP Caused by Acinetobacter Baumannii Complex [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety and pharmacokinetics of OMN6 for hospital-acquired and ventilator-associated pneumonia due to Acinetobacter baumannii c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hospital-acquired Bacterial Pneumonia
• Ventilator-associated Bacterial Pneumonia

Drugs mentioned

• OMN6

Snippet

Sponsor: Omnix Medical Ltd | Conditions: Hospital-acquired Bacterial Pneumonia, Ventilator-associated Bacterial Pneumonia | Phase 2 | Status: RECRUITING